Geschäft · 3.11.20261 Min. Lesezeit
Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The acquisition of our newly licensed Hangzhou facility establishes robust local sourcing capabilities to accelerate and support clinical trials across China HANGZHOU, China, Nov.